Amniotic fluid stem cells to study mTOR signaling in differentiation

Organogenesis

Volumn 8, Issue 3, 2012, Pages 96-100

  Rosner, Margit ^a   Schipany, Katharina ^a   Shanmugasundaram, Bharanidharan ^a   Lubec, Gert ^a   Brandau, Oliver ^a   Hengstschlag̈er, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amniotic fluid; Differentiation; mTOR; RNA interference; Stem cell

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

AMNIOCENTESIS; AMNION FLUID; AMNIOTIC FLUID STEM CELL; CELL DIFFERENTIATION; DNA MODIFICATION; EMBRYO DEATH; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; MAMMAL CELL; NONHUMAN; PROTEIN FUNCTION; REVIEW; STEM CELL;

AMNIOTIC FLUID; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; SIGNAL TRANSDUCTION; STEM CELL RESEARCH; STEM CELLS; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 84871028774     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.22038     Document Type: Review

References (29)

1. Zhu H, Lensch MW, Cahan P, Daley GQ. Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet 2011; 12:266-75; PMID: 21386866; http://dx.doi.org/10.1038/nrg2951
2. Mattis VB, Svendsen CN. Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol 2011; 10:383-94; PMID:21435601; http://dx.doi.org/10.1016/S1474-4422(11)70022-9
3. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011; 13:497-505; PMID: 21540845; http://dx.doi.org/10.1038/ncb0511-497
4. Rosner M, Dolznig H, Schipany K, Mikula M, Brandau O, Hengstschläger M. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget 2011; 2:705-12; PMID:21926447
5. Prusa AR, Hengstschläger M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 2002; 8:RA253-7; PMID:12444390
6. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 2003; 18:1489-93; PMID:12832377; http://dx.doi.org/10.1093/ humrep/deg279
7. Prusa AR, Marton E, Rosner M, Freilinger A, Bernaschek G, Hengstschläger M. Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. J Neural Transm Suppl 2003; 67: 235-42; PMID:15068255; http://dx.doi.org/10.1007/978-3-7091-6721-2-21
8. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, NoortWA, Claas FHJ, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102:1548-9; PMID: 12900350; http://dx.doi.org/10.1182/blood-2003-04-1291
9. Tsai M-S, Lee J-L, Chang Y-J, Hwang S-M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19:1450-6; PMID:15105397; http://dx.doi.org/10.1093/humrep/deh279
10. Prusa AR, Marton E, Rosner M, Bettelheim D, Lubec G, Pollack A, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 2004; 191:309-14; PMID: 15295384; http://dx.doi.org/10.1016/j.ajog.2003.12.014
11. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G, Hengstschläger M. Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 2005; 16:987-92; PMID:16273276
12. Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 2006; 16:329-36; PMID:16617328; http://dx.doi.org/10.1038/sj.cr.7310043
13. Tsai M-S, Hwang S-M, Tsai Y-L, Cheng F-C, Lee J-L, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74:545-51; PMID: 16306422; http://dx.doi.org/10.1095/biolreprod.105.046029
14. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40:75-90; PMID:17227297; http://dx.doi.org/10.1111/j.1365-2184. 2007.00414.x
15. Rehni AK, Singh N, Jaggi AS, Singh M. Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res 2007; 183:95-100; PMID:17619060; http://dx.doi.org/10.1016/j.bbr.2007.05.028
16. Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007; 38:405-13; PMID:17668282; http://dx.doi.org/10.1007/s10735-007-9118-1
17. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100-6; PMID:17206138; http://dx.doi.org/10.1038/nbt1274
18. Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE, Dolznig H, et al. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene 2010; 29:966-77; PMID:19935716; http://dx.doi.org/10.1038/onc.2009.405
19. Orciani M, Emanuelli M, Martino C, Pugnaloni A, Tranquilli AL, Di Primio R. Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells. Int J Immunopathol Pharmacol 2008; 21:595-602; PMID: 18831926
20. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, et al. Human and murine amniotic fluid c-Kit +Lin- cells display hematopoietic activity. Blood 2009; 113:3953-60; PMID:19221036; http://dx.doi.org/10.1182/blood-2008-10- 182105
21. Jezierski A, Gruslin A, Tremblay R, Ly D, Smith C, Turksen K, et al. Probing stemness and neural commitment in human amniotic fluid cells. Stem Cell Rev 2010; 6:199-214; PMID:20221716; http://dx.doi.org/10.1007/s12015-010-9116-7
22. Mareschi K, Rustichelli D, Comunanza V, De Fazio R, Cravero C, Morterra G, et al. Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels. Cytotherapy 2009; 11:534-47; PMID:19548144; http://dx.doi.org/10.1080/14653240902974024
23. Pfeiffer S, McLaughlin D. In vitro differentiation of human amniotic fluid-derived cells: augmentation towards a neuronal dopaminergic phenotype. Cell Biol Int 2010; 34:959-67; PMID:20388119; http://dx.doi.org/10.1042/ CBI20090445
24. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4:423-33; PMID: 19438317; http://dx.doi.org/10.2217/rme.09.12
25. Dobreva MP, Pereira PNG, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 2010; 54:761-77; PMID:20446274; http://dx.doi.org/10.1387/ijdb.092935md
26. Pozzobon M, Ghionzoli M, De Coppi P. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. Pediatr Surg Int 2010; 26:3-10; PMID:19727766; http://dx.doi.org/10.1007/s00383- 009-2478-8
27. Abdulrazzak H, Moschidou D, Jones G, Guillot PV. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface 2010; 7(Suppl 6):S689-706; PMID:20739312; http://dx.doi.org/10.1098/rsif.2010.0347.focus
28. Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto PP, Habibian R, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 2010; 183:1193-200; PMID:20096867; http://dx.doi.org/10.1016/j.juro.2009.11.006
29. Rosner M, Mikula M, Preitschopf A, Feichtinger M, Schipany K, Hengstschläger M. Neurogenic differentiation of amniotic fluid stem cells. Amino Acids 2012; 42:1591-6; PMID:21573873; http://dx.doi.org/10.1007/s00726- 011-0929-8